Literature DB >> 12070430

Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis.

José Antônio Baddini Martinez1, Tieko Yamamoto Martinez, Fabíola Paula Lovetro Galhardo, Carlos Alberto de Castro Pereira.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease and is usually associated with a poor prognosis. IPF patients have a significant impairment in health-related quality of life (HRQL), both in terms of physical and psychological functioning. A substantial number of dyspnea scales are available to clinicians for clinical and research use. The objective of the present study was to investigate how some commonly used dyspnea scales correlate with measurements of HRQL in IPF patients. MATERIAL/
METHODS: A group of 30 patients with IPF who attended a specialized outpatient respiratory clinic were interviewed during a stable period of the disease. HRQL was assessed by the SF-36 questionnaire. Dyspnea was measured by the baseline dyspnea index (BDI), Modified Medical Research Council Scale (MRC), Oxygen Cost Diagram (OCD), clinical element of the Clinical, Roentgenographic and Physiologic score (CRP), and a new dyspnea scale (NS) based on estimates of required oxygen consumption for usual activities.
RESULTS: Patients showed impairments in all HRQL domains except the Pain Index. All dyspnea scales showed significant correlations with both physical and mental HRQL domains. The highest Spearman's coefficients between dyspnea ratings and SF-36 components were obtained using the BDI.
CONCLUSIONS: Dyspnea ratings correlate with HRQL measurements in IPF patients. Dyspnea scales can be used as a measure of HRQL in special circumstances.

Entities:  

Mesh:

Year:  2002        PMID: 12070430

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  16 in total

1.  The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Meilan Han; Rekha Vij; Imre Noth; Eric L Eisenstein; Kevin J Anstrom; Kevin K Brown; Diane Fairclough
Journal:  Respir Med       Date:  2012-07-15       Impact factor: 3.415

2.  Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Authors:  Matthew R Lammi; Robert P Baughman; Surinder S Birring; Anne-Marie Russell; Jay H Ryu; Marybeth Scholand; Oliver Distler; Daphne LeSage; Catherine Sarver; Katerina Antoniou; Kristin B Highland; Otylia Kowal-Bielecka; Joseph A Lasky; Athol U Wells; Lesley Ann Saketkoo
Journal:  Curr Respir Med Rev       Date:  2015

3.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

Review 4.  Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation.

Authors:  Jeffrey J Swigris; Kevin K Brown; Barry J Make; Frederick S Wamboldt
Journal:  Respir Med       Date:  2008-10-10       Impact factor: 3.415

5.  Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.

Authors:  Cristine E Berry; M Bradley Drummond; MeiLan K Han; Daner Li; Cathy Fuller; Andrew H Limper; Fernando J Martinez; Marvin I Schwarz; Frank C Sciurba; Robert A Wise
Journal:  Chest       Date:  2012-09       Impact factor: 9.410

6.  Gender influences Health-Related Quality of Life in IPF.

Authors:  MeiLan K Han; Jeffrey Swigris; Lyrica Liu; Brian Bartholmai; Susan Murray; Nicholas Giardino; Bruce Thompson; Margaret Frederick; Daner Li; Marvin Schwarz; Andrew Limper; Kevin Flaherty; Fernando J Martinez
Journal:  Respir Med       Date:  2009-12-24       Impact factor: 3.415

7.  Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF.

Authors:  Christina Triantafillidou; Effrosyni D Manali; Christina Magkou; Christina Sotiropoulou; Likurgos F Kolilekas; Konstantinos Kagouridis; Dimitra Rontogianni; Spyros A Papiris
Journal:  Diagn Pathol       Date:  2011-04-05       Impact factor: 2.644

8.  Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.

Authors:  Jeffrey J Swigris; Anita L Stewart; Michael K Gould; Sandra R Wilson
Journal:  Health Qual Life Outcomes       Date:  2005-10-07       Impact factor: 3.186

Review 9.  Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis.

Authors:  Amy L Olson; Kevin K Brown; Jeffrey J Swigris
Journal:  Patient Relat Outcome Meas       Date:  2016-05-17

Review 10.  A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis.

Authors:  M F van Jaarsveld; L Gwyther
Journal:  Afr J Thorac Crit Care Med       Date:  2019-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.